Clinical trial
A Phase 2 Study of Imatinib Therapeutic Drug Monitoring in Gastrointestinal Stromal Tumor
NCT05493215 is registered in ClinicalTrials.gov with Reema A. Patel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study of Imatinib Therapeutic Drug Monitoring in Gastrointestinal Stromal Tumor
- Lead sponsor
- Reema A. Patel
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- March 26, 2024
- Completion date
- December 31, 2027
- Enrollment
- 28 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.